An optimized method based on tetracycline-inducible gene expression system T-REx was developed to screen and evaluate Tet repressor (TetR)-expressing cell lines using enhanced green fluorescence protein (EGFP) as reporter gene. To verify the effectiveness of the method, two TetR-expressing Chinese hamster ovary (CHO) cell lines, CHO-TR B2 (stringent) and B5 (less stringent), in which the EGFP genes were variantly controlled by tetracycline, were used to construct cell lines expressing the anti-apoptosis gene survivin upon induction with tetracycline. The resulting stable clones were analyzed for survivin expression. The analysis showed that all four B5-derived clones exhibited leaky survivin expression in the absence of tetracycline, while the B2-derived clones did not. DNA laddering and annexin V/PI staining assays further indicated that although tetracycline-inducible expression of survivin conferred resistance to NH 4 Cl-and staurosporineinduced apoptosis in both the B2-and the B5-derived stable cell lines, the B2-derived cell lines showed more stringent regulation in the absence of tetracycline. This represents successful utilization of the present screening method.
Tetracycline-inducible systems have been applied successfully to cultured mammalian cells to identify the functions of genes of interest. 1, 2) One of the most widely used commercial tetracycline-inducible systems is the T-RExÔ system by Invitrogen, which is based on the binding of tetracycline to the Tet repressor (TetR) and de-repression of the promoter controlling the expression of the gene of interest.
3) Two key plasmids are involved in this system: pcDNA6/TR, which encodes TetR, 4) and pcDNA4/TO, which encodes the gene of interest under the control of a CMV promoter and two tetracycline operator 2 (TetO2) sites from the E. coli Tn10-encoded tetracycline (Tet) resistance operon. 5) In the absence of tetracycline, TetR homodimers bind TetO2 and repress transcription of the downstream gene of interest. Upon addition, tetracycline binds to TetR and causes a conformational change that releases TetR from TetO2, allowing transcription to proceed.
The features of an ideal tetracycline-inducible cell line include low background (leakiness) in the absence of tetracycline and high sensitivity in the presence of it, and this depends greatly on the expression level of TetR. Although Invitrogen provides several cell lines that constitutively express TetR, stable transfection of pcDNA6/TR is required for cell lines that are not commercially available, which is a cumbersome, timeand effort-consuming process. Here we describe an optimized method using EGFP cloned into pcDNA4/TO as reporter gene to obtain the desired TetR-expressing cell lines for the construction of cell lines expressing the gene of interest under the stringent control of tetracycline. EGFP is a variant of wild-type GFP with a modified coding sequence and enhanced fluorescence 6) that responds quickly to regulation by tetracycline, 7) which is advantageous for real-time monitoring of gene expression.
Using this screening method, six CHO DG44 cell lines stably expressing TetR were generated. To verify the effectiveness of the method, CHO-TR B2, the most stringently TetR-controlled clone among all six, and CHO-TR B5, which showed leaky expression of the EGFP reporter gene in the absence of tetracycline, were used to construct stable cell lines expressing the antiapoptosis gene survivin upon induction with tetracycline. Although B5-derived cell lines showed high levels survivin expression and resistance to NH 4 Cl-and staurosporine-induced apoptosis in the presence of tetracycline as in the B2-derived cell lines, they all exhibited leaky survivin expression even without tetracycline induction. On the contrary, all four B2-derived cell lines showed tetracycline tightly controlled survivin expression, which represents a successful application of our method.
Materials and Methods
Generation of the CHO DG44 cell lines which expresses survivin under the control of a Tet-on system. Chinese Hamster Ovary DG44 cells (Invitrogen, Carlsbad, CA) were cultured in minimal essential medium (MEM) supplemented with 10% (v/v) dialyzed fetal bovine serum, HT (100 mM sodium hypoxanthine and 16 mM thymidine), penicillin (100 U/mL), and streptomycin (100 mg/mL) in a humidified incubator at 37 C and 5% CO 2 . pcDNA6/TR (Invitrogen) was linearize by digestion with FspI and transfected into CHO DG44 cells with Lipofectamine 2000. Stable transfectants were selected with 10 mg/mL of blasticidin and maintained in 5 mg/mL of blasticidin.
EGFP was cloned into pcDNA4/TO at the EcoRI and XhoI sites and transfected into the TetR-expressing CHO DG44 cell lines. Twenty-four h after transfection, 1 mg/mL of tetracycline was added to the culture medium, and the cells were observed under a fluorescence microscope for EGFP expression after a further 24 h. Two stable cell lines were selected for transfection with the pcDNA4/TO/survivin plasmid, which was generated by inserting the survivin gene into pcDNA4/TO at the EcoRI and XhoI sites. Stable transfectants were selected with 400 mg/mL of zeocin and maintained in 200 mg/mL of zeocin and 5 mg/mL of blasticidin.
RT-PCR. Total RNA was extracted using an RNeasy kit (Qiagen, Mainz, Germany), and first-strand cDNA was synthesized using a Superscript III kit (Invitrogen). RT-PCR was performed as previously described.
8)
Western blotting. Whole-cell lysates were prepared as described in reference 8. Equal amounts of protein were resolved by 12% SDS-PAGE, electrotransferred to a PVDF membrane (Millipore, Bellerica, MA), and incubated with monoclonal antibodies against survivin (sc-17779, Santa Cruz Biotechnology, CA) and -actin (Sigma-Aldrich, St. Louis, MO). Immunoreactive proteins were detected using a horseradish peroxidase-conjugated antibody to mouse (GE Healthcare Life Sciences, Uppsala, Sweden) and SuperSignal West Dura Extended Duration Substrate (Thermo Scientific Pierce, Rockford, IL).
FITC-annexin V/propidium iodide double staining assay. Cells (2 Â 10 5 /well) were seeded into 6-well plates and cultured for 24 h. Staurosporine was added at 0.2 nM. After 24 h, the cells were harvested and stained with annexin V-FITC and PI, as previously described in reference 8 and analyzed using a FACS Calibur System (BD Biosciences, San Jose, CA).
DNA laddering assay. Cells (2 Â 10 6 /dish) were seeded in 100-mm dishes and treated with 50 mM NH 4 Cl for 72 h with and without 1 mg/ mL tetracycline. Genomic DNA was isolated using an apoptotic DNA ladder extraction kit (Galen, Beijing, China) and treated with RNaseA (1 mg/mL, Sigma-Aldrich) for 30 min. After quantification, 2 mg of each DNA sample was electrophoresed on a 1.5% agarose gel containing ethidium bromide, visualized under UV light, and photographed.
Statistical analysis. One-way ANOVA and post hoc multiple comparisons were performed by SPSS10. All data are presented as mean AE SD. A p-value of less than 0.05 was considered statistically significant.
Results
Establishment of CHO-TR B2 and CHO-TR B5 tetRexpressing cell lines and of the survivin-expressing cell lines derived from CHO-TR B2 and B5
From the six clones obtained by pcDNA6/TR transfection and blasticidin selection, we chose two stable clones for the construction of survivin-expressing cell lines, CHO-TR B2 and CHO-TR B5. CHO-TR B2 was the most stringently TetR-controlled clone of the six clones. It exhibited the fewest EGFP-positive cells in the absence of tetracycline, and the most and brightest EGFP-positive cells in the presence of tetracycline (Fig. 1A-D) . Figure 1E -H show CHO-TR B5, one of the five clones that were not as stringently controlled by TetR as CHO-TR B2, exhibiting many bright EGFPpositive cells (evidence of leaky expression) in the absence of tetracycline.
Then the survivin-expressing cell lines were established by transfection of pcDNA4/TO/survivin into two CHO-TR cell lines and, by selection with zeocin. Four stable clones derived from each CHO-TR cell line were chosen for further analysis of survivin expression as to mRNA and protein levels. As shown in Fig. 2 , survivin was stably expressed and tightly controlled by tetracycline in all four cell lines derived from CHO-TR B2 (Fig. 2A, C) , while all four CHO-TR B5-derived cell lines exhibited leaky survivin expression in the absence of tetracycline (Fig. 2B, D) .
Survivin expression levels were regulated by tetracycline in a time-and dose-dependent manner in cell lines derived from the two CHO-TR stable cell lines CHO-TR B2-derived stable cell line B2-S29 and CHO-TR B5-derived B5-S012 were tested for tetracycline-regulated expression of survivin. The survivin protein level increased in a time-dependent manner following exposure to 1 mg/mL of tetracycline for both B2-S29 (Fig. 3A) and B5-S012 (Fig. 3B) . The two cell lines were then treated for 48 h with various concentrations of tetracycline (0, 0.001, 0.01, 0.1, 0.5, 1, and 5 mg/mL). In B2-S29 (Fig. 3C) , there was no detectable survivin protein in the absence of tetracycline and none at a very low concentration (1 ng/mL), but the survivin protein level increased proportionally to the tetracycline concentration as it increased from 0.01 to 1 mg/mL, indicating that in B2-S29, tetracycline regulates the induction of survivin in a stringent, dose-dependent manner. In B5-S012, low-level survivin expression was detected in the absence of tetracycline and in the presence of tetracycline at concentrations lower than 100 ng/mL (Fig. 3D) , which indicates that less stringent control of tetR in CHO-TR B5 resulted in leaky expression of survivin in the absence of tetracycline.
Tetracycline-induced expression of survivin in CHO-S29 cells conferred apoptosis resistance
During apoptosis, genomic DNA is cleaved by endonucleases, producing DNA laddering, and this is considered a biochemical hallmark of apoptosis. Annexin V-FITC/PI staining assays were performed to demonstrate further the effect of survivin on staurosporine-induced apoptosis. As shown in Fig. 4B , in the absence of tetracycline, B2-S29 cells exhibited a percentage of early and late apoptotic cells (46:47 AE 9:02%) comparable to CHO DG44 (43:31 AE 2:84%) (p > 0:05), but B5-S012 (30:70 AE 2:99%) showed a lower percentage of apoptotic cells than CHO DG44 (p < 0:01). Treatment of these cells with 1 mg/mL of tetracycline resulted in significant decreases in B2-S29 (18:80 AE 3:89%, p < 0:01) and B5-S012 (9:44 AE 2:33%, p < 0:01) apoptosis, but no statistically significant change in CHO DG44 apoptosis (49:4 AE 5:25%, p > 0:05). Thus survivin expression in B2-S29, but not in B5-S012, is stringently controlled by tetracycline. B2-S29 cells (derived from CHO-TR B2) and B5-S012 cells (derived from CHO-TR B5) were cultured with 1 mg/mL of tetracycline and harvested at the indicated times after the addition of tetracycline (A, B), or cultured in the absence (lane 1) and the presence of the indicated concentrations of tetracycline for 48 h (C, D). Equal amounts of protein of whole-cell lysates were subjected to 12% SDS-PAGE and immunoblotted to detect survivin and -actin (loading control).
Discussion
In this study, an EGFP-based screening method was developed to screen and evaluate whether tetR-expressing stable cell lines were stringently regulated. Two stable clones, CHO-TR B2 (stringently regulated) and B5 (less stringently regulated) were selected for the establishment of survivin-expressing cell lines. The resulting clones, in which the anti-apoptosis gene survivin was expressed upon induction with tetracycline, were analyzed for survivin expression. This showed that all four B2-derived clones were stringently controlled by tetracycline, while all four B5-derived clones exhibited leaky survivin expression in the absence of tetracycline. Then one stable cell line from each group, B2-S29 and B5-S012, were tested by DNA laddering and annexin V/PI staining assays, which indicated that although tetracycline-inducible expression of survivin conferred resistance to NH 4 Cl-and staurosporine-induced apoptosis in both cells, B2-S29 showed more stringent control in the absence of tetracycline, which represents a successful utilization of this screening method.
CHO DG44 is a commercially available, dihydrofolate reductase (dhfr)-deficient CHO cell line that grows adherently in FBS-supplemented culture media, it also tolerates serum-free culture conditions, which carries advantages in biopharmaceutical protein production. However, cell death in culture is a major problem that leads to lower yields and poorer quality of products. Hence the mechanism of apoptosis of CHO cells must be explored. Survivin is a small, versatile, structurally unique member of the inhibitor of apoptosis (IAP) protein family in mammalian cells 10) that protects cells from caspase-dependent and caspase-independent apoptosis when overexpressed. 8, 11) Compared to constitutive overexpression, inducible expression of survivin in CHO cells generates more controllable, flexible CHO cell lines, whose anti-apoptosis performance can be regulated. Furthermore, inducible expression rules out the possible site effect originating in different integration loci of the expression vectors, which makes it more suitable for gene function study.
In this study, a modified CHO DG44 cell line that expresses survivin under the induction of tetracycline was generated using an optimized method of screening TetR-expressing cell lines, one that represents not only a viable candidate for biopharmaceutical production, but also a useful tool for further exploration of the mechanisms of apoptosis in CHO cells.
